HCPLive Network

Internal Medicine World Report

Pros and Cons of Echocardiography Technologies in Diagnosing Stress Cardiomyopathy
By Gale Scott
Stress cardiomyopathy is a unique cardiac syndrome in which transient left ventricular (LV) systolic dysfunction mimics acute myocardial infarction (AMI). It is usually brought on by acute emotional or physical stress (or both) and has 3 distinctive features: acute LV wall dysfunction, absence of significant obstructive coronary artery disease, and rapid improvement of LV systolic function within days or weeks.
Hypotension in Hospitalized Heart Failure Patients is Associated Higher Mortality Rate
By Gale Scott
Heart patients who have bouts of hypotension while hospitalized for acute decompensated heart failure (ADHF) have an increased risk of an adverse outcome within 30 days, a multi-institutional study found. Priyesh Patel, MD, and colleagues, writing in Circulation reported on their analysis of results of the ASCEND-HF study.
Case Study: Preventing a Heart Attack in a Runner’s Twin
By Gale Scott
Silent coronary artery disease is often diagnosed too late to prevent a cardiac event. But in a case history involving twin brothers, a team from Liverpool Heart and Chest Hospital, Liverpool, UK shows that investigative imaging of an otherwise healthy man paid off.
Estimation of Cigarette Smoking–Attributable Morbidity in the US
By Adam Hochron
The fact that cigarette smoking is dangerous to a person’s health is not a new concept, but a recent study took a more direct view of just how much damage smokers in the United States do to themselves through what was described as “major medical conditions.”
Childhood Obesity and Risk of Allergy or Asthma
By Adam Hochron
A recent study looked at the relationship between obesity and a child’s risk of developing allergies or an asthmatic condition. Looking at what the authors perceived to be a growing trend of not only an increase in the number obese children but those suffering from new or worsening allergies the authors said they were looking for a link which could help treat the pediatric patients.
New Method Proposed for Levothyroxine Dose Estimation for Benign Disease
By Jackie Syrop
Patients’ body weight (BW) is the accepted way to calculate the starting dose of levothyroxine (LT4) after total thyroidectomy. However, Italian researchers sought to find a new way to improve the accuracy of the LT4 starting dose following total thyroidectomy by identifying other major predictive factors of LT4 requirement.
Bariatric Surgery Leads to Cardiovascular Improvements in Obese Patients
By Rachel Lutz
In morbidly obese but otherwise morbidly obese patients who had bariatric surgery, cardiovascular, and metabolic improvements were noted after 12 months.
Fecal Microbiota Transplantation Treatment Effective in Diarrhea Patients
By Rachel Lutz
In diarrhea patients, a frozen capsule fetal microbiota transplantation treatment can be effective to eliminate symptoms.
Inflammatory Bowel Disease Activated by Inhibitors of Apoptosis
By Rachel Lutz
A literature review published in Trends in Molecular Medicine suggests inflammatory bowel disease can be controlled by levels of inhibitors of apoptosis.
Infectious Disease
Gown Up or Isolate the Patient? Where’s the Evidence?
By Jeannette Wick
Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) have become significant and costly problems—so significant, in fact, that many patients have a basic knowledge of MRSA just from news reports. The Centers for Disease Control and Prevention (CDC) offer a large selection of free tools to educate the public about MRSA and VRE.
β-lactam, Macrolide or Both? Treating Community-Acquired Pneumonia
By Jeannette Wick
A non-inferiority study published in the October 6, 2014 issue of JAMA Internal Medicine looks at these drugs. The researchers report that prescribing β-lactam monotherapy may be as effective as the combination of a macrolide with a β-lactam in certain patients.
Pain Management
Study Further Explores Costs Associated with Chronic Pain
By Jacquelyn Gray
From 2000 to 2007, medications to treat nonmalignant chronic pain (NMCP) came with a price tag of $17.8 billion annually in the US, a Journal of Managed Care & Specialty Pharmacy study found.